National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05XA03	SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	148,566 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	383,826 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 10%	10%	Injectable solution	4,129,004 L.L
A03BB01	SCOBUREN	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	370,901 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 10%	10%	Injectable solution	5,779,226 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	178,731 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 20%	20%	Injectable solution	5,675,800 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 20%	20%	Injectable solution	784,890 L.L
B05BB01	SOLUFLEX LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l		Injectable solution	236,731 L.L
B05XA05	SULFATE DE MAGNESIUM PROAMP	G	Magnesium sulfate - 0.15g/ml	0.15g/ml	Injectable solution	1,400,284 L.L
B05XA05	SULFATE DE MAGNESIUM RENAUDIN	G	Magnesium sulfate - 1.5g/10ml	15%	Injectable solution	434,061 L.L
M05BA08	SIMPLA	G	Zoledronic acid - 5mg/100ml	5mg/100ml	Injectable solution	13,071,402 L.L
P01AB01	SOLUFLEX METRONIDAZOLE	G	Metronidazole - 500mg/100ml	500mg/100ml	Injectable solution	162,541 L.L
B05BB01	SERUFLEX LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l		Injectable solution	216,046 L.L
B05BB01	SERUFLEX LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l		Injectable solution	232,134 L.L
B05BB01	SOLUFLEX LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l		Injectable solution	264,311 L.L
B05BB01	SERUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	204,554 L.L
B05BB01	SOLUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	221,792 L.L
N01AH03	SUFENTANIL RENAUDIN	G	Sufentanil (citrate) - 250mcg/5ml	250mcg/5ml	Injectable solution	3,524,899 L.L
N01AH03	SUFENTANIL RENAUDIN	G	Sufentanil (citrate) - 5mcg/ml	10mcg/2ml	Injectable solution	755,239 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	194,211 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	180,421 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	222,941 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	158,587 L.L
N01BB03	SCANDINIBSA	G	Mepivacaine HCl - 3%	3%	Injectable solution	1,191,988 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	193,062 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	180,421 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	236,731 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	211,449 L.L
N01BB58	SEPTANEST ADRENALINEE	B	Articaine HCl - 72mg/1.8ml, Adrenaline (tartrate) - 0.033mg/1.8ml	1/100,000	Injectable solution	2,945,703 L.L

National Cancer Registry (NCR)